SDHC Gene Pheochromocytoma Type 3 Genetic Test
Welcome to DNA Labs UAE, where we offer the SDHC Gene Pheochromocytoma Type 3 Genetic Test. This test is designed to help diagnose and manage individuals at risk for developing pheochromocytoma type 3, a specific type of tumor that affects the adrenal glands.
Test Components and Price
The SDHC Gene Pheochromocytoma Type 3 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Once the sample is received, the report will be delivered within 3 to 4 weeks.
Method
The SDHC Gene Pheochromocytoma Type 3 Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This advanced method allows for the analysis of multiple genes at once, providing comprehensive information about an individual’s genetic makeup.
Test Type and Doctor
The SDHC Gene Pheochromocytoma Type 3 Genetic Test falls under the category of cancer testing. It is recommended to consult with an oncologist for this test.
Test Department
The SDHC Gene Pheochromocytoma Type 3 Genetic Test is conducted in our Genetics department, where our expert team specializes in genetic testing and analysis.
Pre Test Information
Prior to undergoing the SDHC Gene Pheochromocytoma Type 3 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the SDHC Gene Pheochromocytoma Type 3 NGS Genetic DNA Test gene SDHC.
Test Details
The SDHC gene is responsible for producing a protein called succinate dehydrogenase complex subunit C. This protein is part of the succinate dehydrogenase enzyme complex, which plays a vital role in the energy production process within cells.
Pheochromocytoma type 3 specifically refers to a type of tumor that develops in the adrenal glands. Although these tumors are typically noncancerous, they can cause various symptoms, including high blood pressure, rapid heartbeat, and excessive sweating.
The SDHC Gene Pheochromocytoma Type 3 NGS Genetic Test utilizes next-generation sequencing technology to analyze the SDHC gene. By identifying any genetic variations or mutations associated with pheochromocytoma type 3, this test aids in the diagnosis and management of individuals at risk for this specific tumor.
At DNA Labs UAE, we strive to provide accurate and comprehensive genetic testing services. If you have any questions or would like to schedule an appointment for the SDHC Gene Pheochromocytoma Type 3 Genetic Test, please contact our Genetics department.
Test Name | SDHC Gene Pheochromocytoma type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SDHC Gene Pheochromocytoma type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SDHC Gene Pheochromocytoma type 3 NGS Genetic DNA Test gene SDHC |
Test Details | The SDHC gene is a gene that provides instructions for making a protein called succinate dehydrogenase complex subunit C. This protein is a part of the succinate dehydrogenase enzyme complex, which plays a role in the energy production process in cells. Pheochromocytoma type 3 refers to a specific type of tumor called a pheochromocytoma that develops in the adrenal glands. Pheochromocytomas are usually noncancerous, but they can cause symptoms such as high blood pressure, rapid heartbeat, and excessive sweating. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes at once. It is a high-throughput method that can provide comprehensive information about an individual’s genetic makeup. Therefore, an SDHC gene Pheochromocytoma type 3 NGS genetic test would involve sequencing the SDHC gene using next-generation sequencing technology to identify any genetic variations or mutations that may be associated with the development of pheochromocytoma type 3. This test can help in the diagnosis and management of individuals at risk for this specific type of tumor. |